Literature DB >> 2044292

Arthroscopic treatment of massive rotator cuff tears. Clinical results and biomechanical rationale.

S S Burkhart1.   

Abstract

Ten patients with painful, massive (greater than 5 cm), complete rotator cuff tears involving primarily the supraspinatus were treated with arthroscopic acromioplasty and rotator cuff debridement. All patients except one had normal active motion and strength preoperatively. All patients had roentgenographically normal acromiohumeral distance and an anterior-inferior acromial osteophyte. The goal was to obtain pain relief without loss of motion of strength. This was accomplished in all patients. This study shows that normal shoulder function is possible with a massive unrepaired tear of the rotator cuff. Normal function in the face of an unrepaired cuff tear can occur only if there is a balance of two important force couples, one in the coronal plane and the other in the transverse plane. This balance depends upon the functional integrity of the anterior cuff, the posterior cuff, and the deltoid. In patients whose cuff tears satisfy these anatomic and biomechanical criteria, the achievement of pain relief through arthroscopic debridement and decompression seems to be all that is necessary for normal pain-free function.

Entities:  

Mesh:

Year:  1991        PMID: 2044292

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  65 in total

1.  Five year results of rotator cuff repair.

Authors:  H Habernek; L Schmid; E Frauenschuh
Journal:  Br J Sports Med       Date:  1999-12       Impact factor: 13.800

2.  Diagnostic values of clinical tests for subscapularis lesions.

Authors:  Martin Bartsch; Stefan Greiner; Norbert P Haas; Markus Scheibel
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-04-08       Impact factor: 4.342

Review 3.  [Current procedures for clinical evaluation of the shoulder].

Authors:  M Scheibel; P Habermeyer
Journal:  Orthopade       Date:  2005-03       Impact factor: 1.087

4.  A probabilistic model of glenohumeral external rotation strength for healthy normals and rotator cuff tear cases.

Authors:  Joseph E Langenderfer; James E Carpenter; Marjorie E Johnson; Kai-Nan An; Richard E Hughes
Journal:  Ann Biomed Eng       Date:  2006-02-11       Impact factor: 3.934

5.  Latissimus dorsi transfer for the treatment of massive tears of the rotator cuff.

Authors:  Manuel Zafra; Pedro Carpintero; Carmen Carrasco
Journal:  Int Orthop       Date:  2008-04-05       Impact factor: 3.075

6.  Should massive rotator cuff tears be reconstructed even when only partially repairable?

Authors:  Arnaud Godenèche; Benjamin Freychet; Riccardo Maria Lanzetti; Julien Clechet; Yannick Carrillon; Mo Saffarini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-07       Impact factor: 4.342

7.  Animal model for chronic massive rotator cuff tear: behavioural and histologic analysis.

Authors:  N Sevivas; S C Serra; R Portugal; F G Teixeira; M M Carvalho; N Silva; J Espregueira-Mendes; N Sousa; A J Salgado
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-11-22       Impact factor: 4.342

8.  Decision-making in massive rotator cuff tear.

Authors:  André Thès; Philippe Hardy; Klaus Bak
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-12-11       Impact factor: 4.342

9.  Biceps detachment decreases joint damage in a rotator cuff tear rat model.

Authors:  Stephen J Thomas; Katherine E Reuther; Jennica J Tucker; Joseph J Sarver; Sarah M Yannascoli; Adam C Caro; Pramod B Voleti; Sarah I Rooney; David L Glaser; Louis J Soslowsky
Journal:  Clin Orthop Relat Res       Date:  2014-08       Impact factor: 4.176

10.  Disruption of the anterior-posterior rotator cuff force balance alters joint function and leads to joint damage in a rat model.

Authors:  Katherine E Reuther; Stephen J Thomas; Jennica J Tucker; Joseph J Sarver; Chancellor F Gray; Sarah I Rooney; David L Glaser; Louis J Soslowsky
Journal:  J Orthop Res       Date:  2014-01-25       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.